PetIQ (Nasdaq:PETQ) - Aktienkurs, Nachrichten und Analyse

Die Übersetzung dieser Seite ist experimentell und in Entwicklung. Wir freuen uns über Ihr !

PETQ Aktienübersicht

PetIQ, Inc. ist in den Vereinigten Staaten und international als Unternehmen für Haustiermedikamente und Wellness tätig.

Über das Unternehmen

PETQ fundamental analysis
Snowflake Score
Valuation	3/6
Future Growth	3/6
Past Performance	2/6
Financial Health	1/6
Dividends	0/6

Belohnungen

71.8% unter unserer Schätzung des beizulegenden Zeitwerts gehandelt

Prognostiziertes Gewinnwachstum 71.4% pro Jahr

In diesem Jahr profitabel geworden

Analysten sind sich einig, dass der Aktienkurs um 48.1%

Risikoanalyse

Zinszahlungen sind nicht ausreichend durch Erträge gedeckt

Große einmalige Posten, die sich auf die Finanzergebnisse auswirken

PetIQ, Inc. Wettbewerber

Patterson Companies

NasdaqGS:PDCO

US$2.1b

Henry Schein

NasdaqGS:HSIC

US$8.8b

Cardinal Health

NYSE:CAH

US$24.0b

Pennant Group

NasdaqGS:PNTG

US$682.9m

Preisentwicklung & Leistung

Summary of all time highs, changes and price drops for PetIQ
Historical stock prices
Current Share Price	US$21.94
52 Week High	US$22.98
52 Week Low	US$13.56
Beta	1.76
1 Month Change	18.98%
3 Month Change	32.41%
1 Year Change	55.93%
3 Year Change	-44.64%
5 Year Change	-28.95%
Change since IPO	-5.92%

Aktuelle Nachrichten und Updates

White Brook Capital - PetIQ: Guidance And Street Estimates Are Too Conservative

Apr 20

PetIQ (NASDAQ:PETQ) Seems To Use Debt Quite Sensibly

Apr 13

Recent updates

PetIQ, Inc. (NASDAQ:PETQ) Stock Rockets 26% But Many Are Still Ignoring The Company

Aug 16

PetIQ (NASDAQ:PETQ) Has A Somewhat Strained Balance Sheet

Aug 10

PetIQ's (NASDAQ:PETQ) Returns On Capital Are Heading Higher

Jun 14

PetIQ (NASDAQ:PETQ) May Have Issues Allocating Its Capital

Feb 11

PetIQ gains 1.84 % on $30M stock repurchase program

Sep 06

PetIQ (NASDAQ:PETQ) Use Of Debt Could Be Considered Risky

Aug 23

Here's What's Concerning About PetIQ's (NASDAQ:PETQ) Returns On Capital

Jul 27

Is PetIQ (NASDAQ:PETQ) Using Too Much Debt?

May 06

There Are Reasons To Feel Uneasy About PetIQ's (NASDAQ:PETQ) Returns On Capital

Apr 02

The Prognosis For PetIQ

Feb 12

PetIQ: Economies Of Scale Will Kick In Eventually

Jan 03

PetIQ, Trupanion: Pet Care Industry Small Players Still Not Cheap Enough

Sep 09

Why We Think PetIQ, Inc.'s (NASDAQ:PETQ) CEO Compensation Is Not Excessive At All

Jun 23

These 4 Measures Indicate That PetIQ (NASDAQ:PETQ) Is Using Debt Extensively

May 26

PetIQ, Inc. 2021 Q1 - Results - Earnings Call Presentation

May 07

PetIQ, Inc.'s (NASDAQ:PETQ) About To Shift From Loss To Profit

Apr 01

Have Insiders Sold PetIQ, Inc. (NASDAQ:PETQ) Shares Recently?

Mar 11

Can You Imagine How PetIQ's (NASDAQ:PETQ) Shareholders Feel About The 55% Share Price Increase?

Feb 22

PetIQ, Inc. (NASDAQ:PETQ) Insiders Have Been Selling

Jan 25

Aktionärsrenditen

	PETQ	US Healthcare	US Markt
7D	6.4%	-0.4%	0.8%
1Y	55.9%	1.3%	22.5%

Rendite im Vergleich zur Industrie: PETQ übertraf die Branche US Healthcare, die im vergangenen Jahr eine Rendite von 5.5 erzielte.

Rendite vs. Markt: PETQ übertraf den Markt US, der im vergangenen Jahr eine Rendite von 25.6 erzielte.

Preisvolatilität

Is PETQ's price volatile compared to industry and market?
PETQ volatility
PETQ Average Weekly Movement	5.5%
Healthcare Industry Average Movement	6.6%
Market Average Movement	5.8%
10% most volatile stocks in US Market	15.7%
10% least volatile stocks in US Market	2.8%

Stabiler Aktienkurs: PETQDer Aktienkurs des Unternehmens war in den letzten 3 Monaten unbeständig.

Volatilität im Zeitverlauf: PETQDie wöchentliche Volatilität (6%) ist im vergangenen Jahr stabil geblieben.

Über das Unternehmen

Gegründet	Mitarbeiter	CEO	Website
2010	1,527	Cord Christensen	petiq.com

PetIQ, Inc. ist in den Vereinigten Staaten und international als Unternehmen für Haustiermedikamente und Wellness tätig. Es arbeitet in zwei Segmenten, Produkte und Dienstleistungen. Das Unternehmen bietet Rx Haustier Medikamente, die Flöhe und Zecken, Herzwurm Prävention, Arthritis, Schilddrüse, Diabetes und Schmerzbehandlungen, Antibiotika und andere Spezialitäten Medikamente verkauft; und entwickelt und produziert seine eigenen proprietären Wert-Marken-Produkte, sowie Dritter Markenprodukte für Hunde und Katzen.

PetIQ, Inc.'s Grundlagenzusammenfassung

Wie verhalten sich die Erträge und Einnahmen von PetIQ im Vergleich zum Marktanteil des Unternehmens?
PETQ grundlegende Statistiken
Marktanteil	US$652.76m
Gewinn(TTM)	US$7.34m
Umsatz(TTM)	US$1.12b

88.3x

Kurs-Gewinn-Verhältnis

0.6x

Kurs-Umsatz-Verhältnis

Ist PETQ zu teuer?

Siehe Fair Value und Bewertungsanalyse

Erträge & Einnahmen

Wichtige Rentabilitätsstatistiken aus dem letzten Ergebnisbericht (TTM)
PETQ Gewinn- und Verlustrechnung (TTM)
Einnahmen	US$1.12b
Kosten der Einnahmen	US$854.91m
Bruttogewinn	US$265.02m
Sonstige Ausgaben	US$257.68m
Umsatz	US$7.34m

Zuletzt gemeldete Gewinne

Mar 31, 2024

Datum des nächsten Gewinnberichts

k.A.

Gewinn per Aktie (EPS)	0.25
Bruttomarge	23.66%
Nettogewinnspanne	0.66%
Schulden/Eigenkapital-Verhältnis	186.6%

Wie hat sich PETQ auf lange Sicht entwickelt?

Historische Performance und Vergleiche

PETQ Aktienübersicht

Belohnungen

Risikoanalyse

PetIQ, Inc. Wettbewerber

NasdaqGS:PDCO

US$2.1b

NasdaqGS:HSIC

US$8.8b

NYSE:CAH

US$24.0b

NasdaqGS:PNTG

US$682.9m

Preisentwicklung & Leistung

Aktuelle Nachrichten und Updates

PetIQ, Inc. Provides Earnings Guidance for the Second Quarter of 2024 and Revised Earnings Guidance for the Full Year 2024

First quarter 2024 earnings released: EPS: US$0.51 (vs US$0.33 in 1Q 2023)

PetIQ, Inc. to Report Q1, 2024 Results on May 08, 2024

PetIQ, Inc., Annual General Meeting, Jun 07, 2024

White Brook Capital - PetIQ: Guidance And Street Estimates Are Too Conservative

PetIQ (NASDAQ:PETQ) Seems To Use Debt Quite Sensibly

Recent updates

PetIQ, Inc. Provides Earnings Guidance for the Second Quarter of 2024 and Revised Earnings Guidance for the Full Year 2024

First quarter 2024 earnings released: EPS: US$0.51 (vs US$0.33 in 1Q 2023)

PetIQ, Inc. to Report Q1, 2024 Results on May 08, 2024

PetIQ, Inc., Annual General Meeting, Jun 07, 2024

White Brook Capital - PetIQ: Guidance And Street Estimates Are Too Conservative

PetIQ (NASDAQ:PETQ) Seems To Use Debt Quite Sensibly

PetIQ, Inc. Announces Expansion of Minties Dental Treats Brand with Launch of New Dental Chew for Large-Sized Dogs

Chairman of the Board & CEO exercised options and sold US$362k worth of stock

Full year 2023 earnings released: EPS: US$0.073 (vs US$1.65 loss in FY 2022)

Petiq, Inc. Provides Sales Guidance for the First Quarter and Full Year of 2024

Chairman of the Board & CEO exercised options and sold US$154k worth of stock

PetIQ, Inc. to Report Q4, 2023 Results on Feb 28, 2024

PetIQ: Cost Savings, Higher EBITDA Suggest A Potential Valuation Re-Rate

Chief Financial Officer exercised options and sold US$97k worth of stock

PetIQ, Inc.'s New Sentry™? Portable Calming Diffuser Helps Calm Dogs and Cats During the Busy Holiday Season and Beyond

New major risk - Revenue and earnings growth

Third quarter 2023 earnings released: EPS: US$0.015 (vs US$1.68 loss in 3Q 2022)

Petiq, Inc. Provides Earnings Guidance for the Full Year of 2023

PetIQ, Inc. to Report Q3, 2023 Results on Nov 07, 2023

Investors Will Want PetIQ's (NASDAQ:PETQ) Growth In ROCE To Persist

PetIQ, Inc. (NASDAQ:PETQ) Stock Rockets 26% But Many Are Still Ignoring The Company

PetIQ, Inc. Revises Earnings Guidance for the Full Year 2023

PetIQ (NASDAQ:PETQ) Has A Somewhat Strained Balance Sheet

Price target increased by 13% to US$27.50

Petiq, Inc. Announces Termination of R. Michael Herrman, as Executive Vice President and Corporate Secretary

PetIQ, Inc. to Report Q2, 2023 Results on Aug 08, 2023

PetIQ's (NASDAQ:PETQ) Returns On Capital Are Heading Higher

Petiq, Inc. Provides Earnings Guidance for the Second Quarter of 2023 and Reiterates Earnings Guidance for the Full Year 2023

First quarter 2023 earnings released: EPS: US$0.33 (vs US$0.11 in 1Q 2022)

Chairman of the Board & CEO exercised options and sold US$68k worth of stock

Full year 2022 earnings released: US$1.65 loss per share (vs US$0.56 loss in FY 2021)

Price target decreased by 10% to US$21.75

PetIQ (NASDAQ:PETQ) May Have Issues Allocating Its Capital

PetIQ, Inc. to Report Q4, 2022 Results on Feb 28, 2023

Third quarter 2022 earnings released: US$1.68 loss per share (vs US$0.27 loss in 3Q 2021)

Price target decreased to US$24.25

PetIQ, Inc. to Report Q3, 2022 Results on Nov 09, 2022

President & COO recently bought US$97k worth of stock

PetIQ, Inc. (NasdaqGS:PETQ) announces an Equity Buyback for $30 million worth of its shares.

PetIQ gains 1.84 % on $30M stock repurchase program

PetIQ (NASDAQ:PETQ) Use Of Debt Could Be Considered Risky

Second quarter 2022 earnings released: EPS: US$0.16 (vs US$0.14 in 2Q 2021)

PetIQ, Inc. Provides Sales Guidance for the Third Quarter and Full Year 2022

Here's What's Concerning About PetIQ's (NASDAQ:PETQ) Returns On Capital

PetIQ, Inc. to Report Q2, 2022 Results on Aug 09, 2022

High number of new directors

PetIQ, Inc. Appoints John Pearson as Senior Vice President, Head of Services Division

Price target decreased to US$30.75

PetIQ, Inc. Announces Demise of Larry Bird

President exercised options and sold US$56k worth of stock

First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Is PetIQ (NASDAQ:PETQ) Using Too Much Debt?

High number of new directors

PetIQ, Inc. Provides Revenue Guidance for the Second Quarter, First Half and Full Year 2022

PetIQ, Inc., Annual General Meeting, Jun 22, 2022

PetIQ, Inc. to Report Q1, 2022 Results on May 04, 2022

There Are Reasons To Feel Uneasy About PetIQ's (NASDAQ:PETQ) Returns On Capital

Chairman of the Board & CEO exercised options and sold US$55k worth of stock

Forecast to breakeven in 2022

Erträge & Einnahmen